What does the CheckMate-331 trial of nivolumab vs. chemo for relapsed SCLC tell us? (BMIC-072) - 102204

Spotlight
Video

What does the CheckMate-331 trial of nivolumab vs. chemo for relapsed SCLC tell us? (BMIC-072)

BeaconMedIC has 73 videos Subscribe Here

Loading........
Description: Dr. Jack West reviews the trial design, key results, and implications of the CheckMate-331 trial of nivolumab (Opdivo) vs. standard chemotherapy for relapsed small cell lung cancer.
Shared By : BeaconMedIC
Posted on : 12/20/18
Added : 3 months ago